Links Between the Microbiome and Bone

Journal of Bone and Mineral Research

Volumn 31, Issue 9, 2016, Pages 1638-1646

  Hernandez, Christopher J ^a,b   Guss, Jason D ^a   Luna, Marysol ^a   Goldring, Steven R ^b  

^a School of Chemical and Molecular Engineering   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

FRACTURE; INFLAMMATION; MICROBIOME; OSTEOIMMUNOLOGY; OSTEOPOROSIS

Indexed keywords

CYTOKINE; PREBIOTIC AGENT; PROBIOTIC AGENT; SEX HORMONE;

AGING; BACTERIAL TRANSLOCATION; BONE; BONE DENSITY; BONE GROWTH; BONE MASS; BONE METABOLISM; BONE REMODELING; BONE STRUCTURE; DIABETES MELLITUS; DIET; FRACTURE; FRAGILITY FRACTURE; GASTROINTESTINAL DISEASE; GENETIC BACKGROUND; HOUSING; HUMAN; IMMUNE SYSTEM; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; LACTOBACILLUS; MICROBIOME; NONHUMAN; NUTRITION; OBESITY; OSTEOPOROSIS; REVIEW; RISK FACTOR; STEADY STATE;

EID: 84984944707     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2887     Document Type: Review

References (97)

1. Claesson MJ, O'Sullivan O, Wang Q, et al. Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. PLoS One. 2009; 4(8):e6669.
2. Gordon JI. Honor thy gut symbionts redux. Science. 2012; 336(6086):1251–3.
3. LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, Ventura M. Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol. 2013; 24(2):160–8.
4. Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des. 2009; 15(13):1546–58.
5. Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012; 489(7415):242–9.
6. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature. 2011; 474(7351):327–36.
7. Slack E, Hapfelmeier S, Stecher B, et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science. 2009; 325(5940):617–20.
8. Kamada N, Chen GY, Inohara N, Nunez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol. 2013; 14(7):685–90.
9. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014; 146(6):1489–99.
10. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444(7122):1027–31.
11. Chassaing B, Aitken JD, Gewirtz AT, Vijay-Kumar M. Gut microbiota drives metabolic disease in immunologically altered mice. Adv Immunol. 2012; 116:93–112.
12. Kane AV, Dinh DM, Ward HD. Childhood malnutrition and the intestinal microbiome malnutrition and the microbiome. Pediatr Res. 2015; 77(0):256–62.
13. Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun. 2014; 38:1–12.
14. Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer. 2013; 13(11):800–12.
15. Tang WHW, Hazen SL. The contributory role of gut microbiota in cardiovascular disease. J Clin Invest. 2014; 124(10):4204–11.
16. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature. 2012; 486(7402):222–7.
17. Nagpal R, Yadav H, Marotta F. Gut microbiota: the next-gen frontier in preventive and therapeutic medicine? Front Med (Lausanne). 2014; 1:15.
18. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012; 489(7415):220–30.
19. David LA, Materna AC, Friedman J, et al. Host lifestyle affects human microbiota on daily timescales. Genome Biol. 2014; 15(7):R89.
20. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA. 2011; 108(Suppl 1):4554–61.
21. Phillips ML. Gut reaction: environmental effects on the human microbiota. Environ Health Perspect. 2009; 117(5):A198–A205.
22. Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology-Sgm. 2010; 156:3216–23.
23. Huttenhower C, Knight R, Brown CT, et al. Advancing the microbiome research community. Cell. 2014; 159(2):227–30.
24. Jukes TH, Williams WL. Nutritional effects of antibiotics. Pharmacol Rev. 1953; 5(4):381–420.
25. Ross E, Yacowitz H. Effect of penicillin on growth and bone ash of chicks fed different levels of vitamin-D and phosphorus. Poultry Sci. 1954; 33(2):262–5.
26. Rusoff LL, Fussell JM, Hyde CE, Crown RM, Gall LS. Parenteral administration of aureomycin to young calves with a note on mode of action. J Dairy Sci. 1954; 37(5):488–97.
27. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014; 157(1):121–41.
28. Li Y, Toraldo G, Li A, et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood. 2007; 109(9):3839–48.
29. Pacifici R. T cells, osteoblasts, and osteocytes: interacting lineages key for the bone anabolic and catabolic activities of parathyroid hormone. Ann N Y Acad Sci. 2016; 1364(1):11–24.
30. Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013; 504(7480):451–5.
31. Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013; 504(7480):446–50.
32. Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013; 341(6145):569–73.
33. Kiyono H, McGhee JR, Wannemuehler MJ, Michalek SM. Lack of oral tolerance in C3H/HeJ mice. J Exp Med. 1982; 155(2):605–10.
34. Wannemuehler MJ, Kiyono H, Babb JL, Michalek SM, McGhee JR. Lipopolysaccharide (LPS) regulation of the immune response: LPS converts germfree mice to sensitivity to oral tolerance induction. J Immunol. 1982; 129(3):959–65.
35. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol. 1997; 159(4):1739–45.
36. Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunol Rev. 2011; 241(1):241–59.
37. Potgieter M, Bester J, Kell DB, Pretorius E. The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev. 2015; 39(4):567–91.
38. Takami M, Kim N, Rho J, Choi Y. Stimulation by toll-like receptors inhibits osteoclast differentiation. J Immunol. 2002; 169(3):1516–23.
39. Zou W, Bar-Shavit Z. Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res. 2002; 17(7):1211–8.
40. Itoh K, Udagawa N, Kobayashi K, et al. Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J Immunol. 2003; 170(7):3688–95.
41. Chamberlain ND, Vila OM, Volin MV, et al. TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-alpha levels. J Immunol. 2012; 189(1):475–83.
42. Kim SJ, Chen Z, Chamberlain ND, et al. Ligation of TLR5 promotes myeloid cell infiltration and differentiation into mature osteoclasts in rheumatoid arthritis and experimental arthritis. J Immunol. 2014; 193(8):3902–13.
43. Kassem A, Henning P, Kindlund B, Lindholm C, Lerner UH. TLR5, a novel mediator of innate immunity-induced osteoclastogenesis and bone loss. FASEB J. 2015; 29(11):4449–60.
44. O'Boyle CJ, MacFie J, Mitchell CJ, Johnstone D, Sagar PM, Sedman PC. Microbiology of bacterial translocation in humans. Gut. 1998; 42(1):29–35.
45. Tsujimoto H, Ono S, Mochizuki H. Role of translocation of pathogen-associated molecular patterns in sepsis. Dig Surg. 2009; 26(2):100–9.
46. Berg RD. Bacterial translocation from the gastrointestinal tract. Adv Exp Med Biol. 1999; 473:11–30.
47. Fung TC, Bessman NJ, Hepworth MR, et al. Lymphoid-tissue-resident commensal bacteria promote members of the IL-10 cytokine family to establish mutualism. Immunity. 2016; 44(3):634–46.
48. Kapadia BH, Berg RA, Daley JA, Fritz J, Bhave A, Mont MA. Periprosthetic joint infection. Lancet. 2016; 387(10016):386–94.
49. Marcus R, Dempster DW, Bouxsein ML. The nature of osteoporosis. In: Marcus R, Feldman D, Dempster DW, Luckey M, Cauley JA, editors. Osteoporosis. 4th ed., vol. 1. Waltham, MA: Academic Press; 2013. p. 21–30.
50. Nordin BEC. Reflections on osteoporosis. In: Marcus R, Feldman D, Dempster DW, Luckey M, Cauley JA, editors. Osteoporosis. 4th ed., vol. 1. Waltham, MA: Academic Press; 2013. p. 31–50.
51. Mariat D, Firmesse O, Levenez F, et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009; 9:123.
52. Jackson M, Jeffery IB, Beaumont M, et al. Signatures of early frailty in the gut microbiota. Genome Med. 2016; 8(1):8.
53. Fitzgerald RJ. Gnotobiotic contribution to oral microbiology. J Dent Res. 1963; 2:549–52.
54. Bibiloni R. Rodent models to study the relationships between mammals and their bacterial inhabitants. Gut Microbes. 2012; 3(6):536–43.
55. Falk PG, Hooper LV, Midtvedt T, Gordon JI. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev. 1998; 62(4):1157–70.
56. Williams SC. Gnotobiotics. Proc Natl Acad Sci USA. 2014; 111(5):1661.
57. Sjogren K, Engdahl C, Henning P, et al. The gut microbiota regulates bone mass in mice. J Bone Miner Res. 2012; 27(6):1357–67.
58. Li JY, Chassaing B, Tyagi AM, et al. Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics. J Clin Invest. 2016; 126(6):2049–63.
59. Schwarzer M, Makki K, Storelli G, et al. Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition. Science. 2016; 351(6275):854–7.
60. Jepsen KJ. Functional interactions among morphologic and tissue quality traits define bone quality. Clin Orthop Relat Res. 2011; 469(8):2150–9.
61. O'Connor A, Quizon PM, Albright JE, Lin FT, Bennett BJ. Responsiveness of cardiometabolic-related microbiota to diet is influenced by host genetics. Mamm Genome. 2014; 25(11–12):583–99.
62. Cullender TC, Chassaing B, Janzon A, et al. Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut. Cell Host Microbe. 2013; 14(5):571–81.
63. Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010; 328(5975):228–31.
64. Uitterlinden AG, Zillikens MC, Rivadeneira F. Genetic determinants of osteoporosis. In: Marcus R, Feldman D, Dempster DW, Luckey M, Cauley JA, editors. Osteoporosis. 4th ed., vol. 1. Waltham, MA: Elsevier; 2014. p. 563–604.
65. Goodrich JK, Waters JL, Poole AC, et al. Human genetics shape the gut microbiome. Cell. 2014; 159(4):789–99.
66. Cho I, Yamanishi S, Cox L, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012; 488(7413):621–6.
67. Cox LM, Yamanishi S, Sohn J, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 2014; 158(4):705–21.
68. Nobel YR, Cox LM, Kirigin FF, et al. Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment. Nat Commun. 2015; 6:7486.
69. Blanton LV, Charbonneau MR, Salih T, et al. Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children. Science. 2016; 351(6275).
70. Britton RA, Irwin R, Quach D, et al. Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol. 2014; 229(11):1822–30.
71. Ohlsson C, Engdahl C, Fak F, et al. Probiotics protect mice from ovariectomy-induced cortical bone loss. PLoS One. 2014; 9(3):e92368.
72. Pytlik M, Folwarczna J, Janiec W. Effects of doxycycline on mechanical properties of bones in rats with ovariectomy-induced osteopenia. Calcif Tissue Int. 2004; 75(3):225–30.
73. Williams S, Wakisaka A, Zeng QQ, et al. Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats. Bone. 1996; 19(6):637–44.
74. Koren O, Goodrich JK, Cullender TC, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012; 150(3):470–80.
75. McCabe LR, Irwin R, Schaefer L, Britton RA. Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice. J Cell Physiol. 2013; 228(8):1793–8.
76. Zhang J, Motyl KJ, Irwin R, MacDougald OA, Britton RA, McCabe LR. Loss of bone and Wnt10b expression in male type 1 diabetic mice is blocked by the probiotic lactobacillus reuteri. Endocrinology. 2015; 156(9):3169–82.
77. Scholz-Ahrens KE, Schaafsma G, van den Heuvel EG, Schrezenmeir J. Effects of prebiotics on mineral metabolism. Am J Clin Nutr. 2001; 73(2 Suppl):459S–64S.
78. Scholz-Ahrens KE, Ade P, Marten B, et al. Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr. 2007; 137(3 Suppl 2):838S–46S.
79. Roberfroid MB, Cumps J, Devogelaer JP. Dietary chicory inulin increases whole-body bone mineral density in growing male rats. J Nutr. 2002; 132(12):3599–602.
80. Takahara S, Morohashi T, Sano T, Ohta A, Yamada S, Sasa R. Fructooligosaccharide consumption enhances femoral bone volume and mineral concentrations in rats. J Nutr. 2000; 130(7):1792–5.
81. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA. 2007; 104(34):13780–5.
82. Bikle DD. Osteoporosis in gastrointestinal, pancreatic and hepatic diseases. In: Marcus R, Feldman D, Nelson DA, Rosen CJ, editors. Osteoporosis. 3rd ed., vol. 2. San Diego, CA: Elsevier Academic Press; 2008. p. 1203–26.
83. Ali T, Lam D, Bronze MS, Humphrey MB. Osteoporosis in inflammatory bowel disease. Am J Med. 2009; 122(7):599–604.
84. Ghishan FK, Kiela PR. Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol. 2011; 300(2):G191–201.
85. Ciucci T, Ibanez L, Boucoiran A, et al. Bone marrow Th17 TNFalpha cells induce osteoclast differentiation, and link bone destruction to IBD. Gut. 2015; 64(7):1072–81.
86. Dresner-Pollak R, Gelb N, Rachmilewitz D, Karmeli F, Weinreb M. Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology. 2004; 127(3):792–801.
87. Akhter MP, Jung LK. Decreased bone strength in HLA-B27 transgenic rat model of spondyloarthropathy. Rheumatology. 2007; 46(8):1258–62.
88. Hamdani G, Gabet Y, Rachmilewitz D, Karmeli F, Bab I, Dresner-Pollak R. Dextran sodium sulfate-induced colitis causes rapid bone loss in mice. Bone. 2008; 43(5):945–50.
89. Harris L, Senagore P, Young VB, McCabe LR. Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice. Am J Physiol Gastrointest Liver Physiol. 2009; 296(5):G1020–9.
90. Ooi JH, Li Y, Rogers CJ, Cantorna MT. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J Nutr. 2013; 143(10):1679–86.
91. Goodrich JK, Di Rienzi SC, Poole AC, et al. Conducting a microbiome study. Cell. 2014; 158(2):250–62.
92. Lundberg R, Toft MF, August B, Hansen AK, Hansen CH. Antibiotic-treated versus germ-free rodents for microbiota transplantation studies. Gut Microbes. 2016; 7(1):68–74.
93. Hansen CH, Nielsen DS, Kverka M, et al. Patterns of early gut colonization shape future immune responses of the host. PLoS One. 2012; 7(3):e34043.
94. Hansen CH, Metzdorff SB, Hansen AK. Customizing laboratory mice by modifying gut microbiota and host immunity in an early “window of opportunity”. Gut Microbes. 2013; 4(3):241–5.
95. Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science. 2016; 352(6285):539–44.
96. Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012; 488(7410):178–84.
97. Byrne FR, Morony S, Warmington K, et al. CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin. Gut. 2005; 54(1):78–86.